Single-dose etomidate does not increase mortality in patients with sepsis: A systematic review and meta-analysis of randomized controlled trials and observational studies

Chest

Volumn 147, Issue 2, 2015, Pages 335-346

  Gu, Wan Jie ^a   Wang, Fei ^b   Tang, Lu ^b   Liu, Jing Chen ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ETOMIDATE; INTRAVENOUS ANESTHETIC AGENT;

ADRENAL INSUFFICIENCY; ARTICLE; CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; LENGTH OF STAY; META ANALYSIS; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SEPSIS; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; ADULT; ENDOTRACHEAL INTUBATION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; ANESTHETICS, INTRAVENOUS; ETOMIDATE; HUMANS; INTUBATION, INTRATRACHEAL; OBSERVATIONAL STUDY AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS;

EID: 84928048108     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-1012     Document Type: Article

References (41)

1. Sakles JC, Laurin EG, Rantapaa AA, Panacek EA. Airway management in the emergency department: a one-year study of 610 tracheal intubations. Ann Emerg Med. 1998; 31 ( 3): 325-332.
2. Zed PJ, Abu-Laban RB, Harrison DW. Intubating conditions and hemodynamic eff ects of etomidate for rapid sequence intubation in the emergency department: an observational cohort study. Acad Emerg Med. 2006; 13 ( 4): 378-383.
3. de Jong FH, Mallios C, Jansen C, Scheck PA, Lamberts SW. Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation. J Clin Endocrinol Metab. 1984; 59 ( 6): 1143-1147.
4. Vinclair M, Broux C, Faure P, et al. Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med. 2008; 34 ( 4): 714-719.
5. Annane D, Maxime V, Ibrahim F, Alvarez JC, Abe E, Boudou P. Diagnosis of adrenal insuffi ciency in severe sepsis and septic shock. Am J Respir Crit Care Med. 2006; 174 ( 12): 1319-1326.
6. van den Heuvel I, Wurmb TE, Böttiger BW, Bernhard M. Pros and cons of etomidate- more discussion than evidence? Curr Opin Anaesthesiol. 2013; 26 ( 4): 404-408.
7. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-269.
8. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977; 33 ( 1): 159-174.
9. Higgins JP, Altman DG, Gøtzsche PC, et al; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343: d5928.
10. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Ottawa Hospital Research Institute website. http:// www. ohri. ca/programs/clinical-epidemiology/ oxford. asp. Accessed June 9, 2014.
11. Higgins JP, Th ompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327 ( 7414): 557-560.
12. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50 ( 4): 1088-1101.
13. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315 ( 7109): 629-634.
14. den Brinker M, Hokken-Koelega AC, Hazelzet JA, de Jong FH, Hop WC, Joosten KF. One single dose of etomidate negatively infl uences adrenocortical performance for at least 24h in children with meningococcal sepsis. Intensive Care Med. 2008; 34 ( 1): 163-168.
15. den Brinker M, Joosten KF, Liem O, et al. Adrenal insuffi ciency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab. 2005; 90 ( 9): 5110-5117.
16. Jabre P, Combes X, Lapostolle F, et al; KETASED Collaborative Study Group. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet. 2009; 374 ( 9686): 293-300.
17. Tekwani KL, Watts HF, Sweis RT, Rzechula KH, Kulstad EB. A comparison of the eff ects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study. Ann Emerg Med. 2010; 56 ( 5): 481-489.
18. Annane D, Sébille V, Charpentier C, et al. Eff ect of treatment with low doses of hydrocortisone and fl udrocortisone on mortality in patients with septic shock [published correction appears in JAMA. 2008;300(14):1652].
19. JAMA. 2002; 288 ( 7): 862-871.
20. Cuthbertson BH, Sprung CL, Annane D, et al. The eff ects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med. 2009; 35 ( 11): 1868-1876.
21. Cherfan AJ, Tamim HM, AlJumah A, et al. Etomidate and mortality in cirrhotic patients with septic shock. BMC Clin Pharmacol. 2011; 11: 22.
22. Mohammad Z, Afessa B, Finkielman JD. The incidence of relative adrenal insuffi-ciency in patients with septic shock aft er the administration of etomidate. Crit Care. 2006; 10 ( 4): R105.
23. Ray DC, McKeown DW. Eff ect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock. Crit Care. 2007; 11 ( 3): R56.
24. Riché FC, Boutron CM, Valleur P, et al. Adrenal response in patients with septic shock of abdominal origin: relationship to survival. Intensive Care Med. 2007; 33 ( 10): 1761-1766.
25. Kim TY, Rhee JE, Kim KS, Cha WC, Suh GJ, Jung SK. Etomidate should be used carefully for emergent endotracheal intubation in patients with septic shock. J Korean Med Sci. 2008; 23 ( 6): 988-991.
26. Tekwani KL, Watts HF, Chan CW, Nanini S, Rzechula KH, Kulstad EB. The eff ect of single-bolus etomidate on septic patient mortality: a retrospective review. West J Emerg Med. 2008; 9 ( 4): 195-200.
27. Tekwani KL, Watts HF, Rzechula KH, Sweis RT, Kulstad EB. A prospective observational study of the eff ect of etomidate on septic patient mortality and length of stay. Acad Emerg Med. 2009; 16 ( 1): 11-14.
28. Dmello D, Taylor S, O'Brien J, Matuschak GM. Outcomes of etomidate in severe sepsis and septic shock. Chest. 2010; 138 ( 6): 1327-1332.
29. Ehrman R, Wira C, Lomax A, et al. Etomidate use in severe sepsis and septic shock patients does not contribute to mortality. Intern Emerg Med. 2011; 6 ( 3): 253-257.
30. Jung B, Clavieras N, Nougaret S, et al. Eff ects of etomidate on complications related to intubation and on mortality in septic shock patients treated with hydrocortisone: a propensity score analysis. Crit Care. 2012; 16 ( 6): R224.
31. McPhee LC, Badawi O, Fraser GL, et al. Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: analysis of a large electronic ICU database. Crit Care Med. 2013; 41 ( 3): 774-783.
32. Sunshine JE, Deem S, Weiss NS, et al. Etomidate, adrenal function, and mortality in critically ill patients. Respir Care. 2013; 58 ( 4): 639-646.
33. Alday NJ, Jones GM, Kimmons LA, Phillips GS, McCallister JW, Doepker BA. Eff ects of etomidate on vasopressor use in patients with sepsis or severe sepsis: a propensity-matched analysis. J Crit Care. 2014; 29 ( 4): 517-522.
34. Th ompson Bastin ML, Baker SN, Weant KA. Eff ects of etomidate on adrenal suppression: a review of intubated septic patients. Hosp Pharm. 2014; 49( 2): 177-183.
35. Chan CM, Mitchell AL, Shorr AF. Etomidate is associated with mortality and adrenal insuffi ciency in sepsis: a meta-analysis. Crit Care Med. 2012; 40 ( 11): 2945-2953.
36. Albert SG, Ariyan S, Rather A. The eff ect of etomidate on adrenal function in critical illness: a systematic review. Intensive Care Med. 2011; 37 ( 6): 901-910.
37. Payen JF, Dupuis C, Trouve-Buisson T, et al. Corticosteroid aft er etomidate in critically ill patients: a randomized controlled trial. Crit Care Med. 2012; 40( 1): 29-35.
38. Molenaar N, Bijkerk RM, Beishuizen A, et al. Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate. Crit Care. 2012; 16 ( 4): R121.
39. Khan KS, Hayes I, Buggy DJ. Pharmacology of anaesthetic agents I: intravenous anaesthetic agents. Contin Educ Anaesth Crit Care Pain. 2014; 14 ( 3): 100-105.
40. Jung B, Nougaret S, Chanques G, et al. The absence of adrenal gland enlargement during septic shock predicts mortality: a computed tomography study of 239 patients. Anesthesiology. 2011; 115 ( 2): 334-343.
41. Wang C, Sun J, Zheng J, et al. Low-dose hydrocortisone therapy attenuates septic shock in adult patients but does not reduce 28-day mortality: a meta-analysis of randomized controlled trials. Anesth Analg. 2014; 118 ( 2): 346-357.